货号：UP205049300
| 产品信息 | |
| 产品名称： | Losartan potassium |
| 中文名称： | 氯沙坦钾(请以英文为准,中文仅做参考) |
| CAS号： | 124750-99-8 |
| 分子式： | C22H22ClKN6O |
| 分子量： | 461.00 |
| MDL NO： | MFCD02092704 |
| 标准纯度： | 98+% (UP205049300) |
| 沸点： | 682°C at 760 mmHg |
| 储存： | Inert atmosphere,Room Temperature (UP205049300) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
抑制剂/受体激动剂
G蛋白偶联受体/G蛋白
Bombesin Receptor
抑制剂/受体激动剂
G蛋白偶联受体/G蛋白
Adenosine Receptor
抑制剂/受体激动剂
G蛋白偶联受体/G蛋白
Bradykinin Receptor
Dexelvucitabine
UP254939436134379-77-4
INO-1001
UP1127261553544-24-9
WIKI4
UP335457016838818-26-1
Ibutamoren Mesylate
UP966423060159752-10-0
LECIRELIN
UP65359667161012-19-9
Rimantadine
UP17378950613392-28-4
Nexturastat A
UP7146323681403783-31-2
KJ Pyr 9
UP299341148581073-80-5
CPI-455 hydrochloride
UP2324881362095432-28-1
AT-101 acetic acid Salt
UP412408796866541-93-7
4-Hydroxybenzoic acid
UP94631322799-96-7
Nafamostat hydrochloride
UP65390333880251-32-7
Salermide
UP8098154401105698-15-4
NCL-1
UP8892409192199214-20-3
Epoxomicin
UP820527281134381-21-8
Fasudil Hydrochloride
UP770755838105628-07-7
Nafamostat mesylate
UP58117106682956-11-4
Rucaparib phosphate
UP911921401459868-92-9
Exendin-4 Acetate
UP719860616914454-01-6
SID 3712249
UP668591152522606-67-3
Fimasartan
UP905569400247257-48-3
Laninamivir Octanoate
UP697744142203120-46-1
CM-272
UP8503349941846570-31-7
EX-527 R-enantiomer
UP714185246848193-69-1
beta-Hydroxypropiovanillone
UP6317261522196-18-1
Sirtinol
UP129370095410536-97-9
Poloxin
UP989260975321688-88-4
LY294002
UP384272212154447-36-6
SRT2104
UP1565078981093403-33-8
Angiotensin 1-7
UP86161484451833-78-4
Inauhzin
UP616078775309271-94-1
AZD2461
UP1113476931174043-16-3
6-Benzyl-4-chloro-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine
UP618135341914612-23-0
Ginkgolide B
UP75071907615291-77-7
PD123319 Ditrifluoroacetate
UP968796757136676-91-0
Azilsartan medoxomil
UP305842054863031-21-4
Aloin A
UP2826788981415-73-2
T 5601640
UP930681846924473-59-6
Losartan potassium
UP205049300124750-99-8